• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHZ2200260 艾考恩丙替片 cobicistat;elvitegravir;emtricitabine;tenofovir alafenamide Tablet Chemical Drugs License Renew 2022-09-24 view
JYHB2101447 艾考恩丙替片 cobicistat;elvitegravir;emtricitabine;tenofovir alafenamide Tablet Chemical Drugs Supplementary Application 2021-09-29 view
JYHB2002322 艾考恩丙替片 cobicistat;elvitegravir;emtricitabine;tenofovir alafenamide Tablet Chemical Drugs Supplementary Application 2020-11-18 吉利德(上海)医药科技有限公司 Gilead (Shanghai) Pharmaceutical Technology Co Ltd Filed 2020-12-02 view
JYHB2001728 艾考恩丙替片 cobicistat;elvitegravir;emtricitabine;tenofovir alafenamide Tablet Chemical Drugs Supplementary Application 2020-09-09 吉利德(上海)医药科技有限公司 Gilead (Shanghai) Pharmaceutical Technology Co Ltd Certificate Issued 2020-12-18 view
JYHB2001096 艾考恩丙替片 cobicistat;elvitegravir;emtricitabine;tenofovir alafenamide Tablet Chemical Drugs Supplementary Application 2020-07-06 吉利德(上海)医药科技有限公司 Gilead (Shanghai) Pharmaceutical Technology Co Ltd Certificate Issued 2021-02-01 view
JYHB1901311 艾考恩丙替片 cobicistat;elvitegravir;emtricitabine;tenofovir alafenamide Tablet Chemical Drugs Supplementary Application 2019-11-06 吉利德(上海)医药科技有限公司 Gilead (Shanghai) Pharmaceutical Technology Co Ltd Certificate Issued 2020-01-16 view
JYHB1900112 艾考恩丙替片 cobicistat;elvitegravir;emtricitabine;tenofovir alafenamide Tablet Chemical Drugs Supplementary Application 2019-02-01 吉利德(上海)医药科技有限公司 Gilead (Shanghai) Pharmaceutical Technology Co Ltd Certificate Issued 2019-04-29 view
JYHB1900111 艾考恩丙替片 cobicistat;elvitegravir;emtricitabine;tenofovir alafenamide Tablet Chemical Drugs Supplementary Application 2019-01-28 吉利德(上海)医药科技有限公司 Gilead (Shanghai) Pharmaceutical Technology Co Ltd Filed 2019-01-30 view